Authorized purpose: Semi-automatic ovarian follicle count and size assessment from transvaginal ultrasound, with clinician verification before clinical use.
Clinical role
Follicle segmentation, measurement and counting
Images and patients
Ultrasound · Pelvis/Ovaries
Key limitation
Keep in mind: Results must be manually verified in a DICOM viewer before clinical use. The submitted algorithms are fixed; the software does not replace clinician assessment.
Clinical detailsPurpose, workflow fit, evidence, and safety record
Workflow navigation pilot
Workflow role has not yet been reviewed for this navigation pilot.
A tag identifies a documented role; it does not establish compatibility or local acceptance. Methods and sources
What does this software do?Authorized purpose: Semi-automatic ovarian follicle count and size assessment from transvaginal ultrasound, with clinician verification before clinical use.
Which images or clinical context are in scope?Modality: Ultrasound Anatomy or clinical context: Pelvis/Ovaries Input: DICOM 2D+t cine loops or 3D transvaginal ultrasound scans capturing an ovarian sweep.
Who uses it?Intended users: Clinicians interpreting transvaginal ovarian ultrasound examinations.
What does the software produce?Output: Follicle contours, two orthogonal diameters and volume, and counts per ovary in size groups below 10 mm, at least 10 but below 17 mm, and at least 17 mm.
What is its most important limitation?Key limitation: Results must be manually verified in a DICOM viewer before clinical use. The submitted algorithms are fixed; the software does not replace clinician assessment.
Clinical takeaway. Clinical role: Semi-automatic ovarian follicle count and size assessment from transvaginal ultrasound, with clinician verification before clinical use.
Evidence takeaway. Evidence from the reviewed source record: The FDA summary describes a held-out test set of 138 scans from 64 patients at five clinics, including 45 US scans, with expert-reviewed reference contours and patient-separated development/test data.
Evidence context
Evidence context not reviewed for this FDA record.
Public-label constraints
Label constraints have not been reviewed for this exact FDA record. Unknown is not all ages or evidence of unsuitability.
Public-label constraints, not patient-level eligibility or a medical recommendation. Training and evaluation populations are separate. Read the original labeling and confirm the exact release and protocol.
Purpose
Semi-automatic ovarian follicle count and size assessment from transvaginal ultrasound, with clinician verification before clinical use.
Follicle contours, two orthogonal diameters and volume, and counts per ovary in size groups below 10 mm, at least 10 but below 17 mm, and at least 17 mm.
Exact FDA submission
Checked 2026-09-05
Restores the comparison operators missing from the baseline size-bin text.
Results must be manually verified in a DICOM viewer before clinical use. The submitted algorithms are fixed; the software does not replace clinician assessment.
The FDA summary describes a held-out test set of 138 scans from 64 patients at five clinics, including 45 US scans, with expert-reviewed reference contours and patient-separated development/test data.
Exact FDA submission
Checked 2026-09-05
Development involved 2132 patients at seven centers and 6404 DICOM datasets; those are not the test denominator. No IVF outcome benefit is inferred.
Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.
Evidence summary
The FDA summary describes a held-out test set of 138 scans from 64 patients at five clinics, including 45 US scans, with expert-reviewed reference contours and patient-separated development/test data.
FDA source
Exact FDA submission
Checked 2026-09-05
Development involved 2132 patients at seven centers and 6404 DICOM datasets; those are not the test denominator. No IVF outcome benefit is inferred.
No product-wide sensitivity with a verified exact-release endpoint/threshold is promoted; follicle measurement and count errors are distinct endpoints.
Reported specificity
Not established in reviewed sources
Reviewed sources checked
Exact FDA submission
Checked 2026-09-05
No product-wide specificity with a verified exact-release endpoint/threshold is promoted.
No contextualized exact-version metric has completed evidence review. Regulatory-document values, when available, are shown above with their limitations.
K252332 held-out follicle measurement and counting validation
DesignMulticenter held-out standalone evaluation against expert-reviewed follicle reference contours
Population138 transvaginal ultrasound scans from 64 patients at five clinics; 45 scans from the United States
Scopeexact submission
Tested versionFolliscan configuration submitted in K252332
Samplen=64
Sites5
IndependenceSponsor or vendor study
K252332
Sample size is patients, not scans or follicles. Patient-level split avoids development/test overlap. The summary's volume error/unit presentation is not promoted as a normalized numeric metric.
IT implementationDeployment, interfaces, data handling, and support
System and version relationships
Match the AI release, system build, configuration and region. Source documentation does not establish acceptance of an installed system.
No specific system/version pairing has completed review for this FDA record. A broad DICOM or product-family statement does not establish a named viewer build's support.
Public source context, not tested interoperability. Each hop needs its own release/configuration evidence. Missing or unavailable routes are not documented incompatibility. All local tests are planned, not passed; no installed-system acceptance is recorded.
Acquisition/source → routing → AI processing → returned objects → viewer/worklist/report → support owner
No specific route context has been source-reviewed for this record. Obtain both endpoint builds and documents; this is not a finding of incompatibility.
Acquisition/source
Source context, not route validation: DICOM 2D+t cine loops or 3D transvaginal ultrasound scans capturing an ovarian sweep.
Scope: Exact FDA submission.
Confirm scanner/model, protocol, series completeness and both software builds.
Source context, not route validation: DICOM image submission and review workflow, with API use dependent on a validated connector and manual verification of results.
Scope: Exact FDA submission.
Name gateways, destinations, transfer rules and failure visibility; a DICOM statement does not prove a route.
Source context, not route validation: Follicle contours, two orthogonal diameters and volume, and counts per ovary in size groups below 10 mm, at least 10 but below 17 mm, and at least 17 mm.
Scope: Exact FDA submission. Restores the comparison operators missing from the baseline size-bin text.
Confirm object classes, units, references and whether findings, overlays or measurements reach their intended destination.
Unresolved route: Follicle contours, two orthogonal diameters and volume, and counts per ovary in size groups below 10 mm, at least 10 but below 17 mm, and at least 17 mm.
Scope: Exact FDA submission. Restores the comparison operators missing from the baseline size-bin text.
Confirm the named viewer/worklist/report build, display behavior and report transfer. Output support alone does not establish this endpoint. The displayed source describes output, not validated end-to-end delivery.
Unresolved route: Not established for the exact route.
Scope: Scope not established.
Name the local, platform and AI supplier support owners and escalation path.
Planned local route tests
No tests below have been performed or accepted.
Patient/study identity (planned). Use approved non-patient test data to verify identifiers, accession and result-to-study linkage at every hop.
Study completeness (planned). Test missing views/series, partial transfer, late arrivals, priors and unsupported acquisition inputs; confirm explicit refusal or fallback.
Ordering and duplicates (planned). Send out-of-order, repeated and corrected studies; verify worklist order, deduplication and no misleading stale results.
Report transfer (planned). Verify output object types, annotations, units, report content, destination and availability of original images.
Access (planned). Verify authorized roles, audit trail, denied access and support ownership at each destination.
Latency and failures (planned). Agree a workload and turnaround target; test queues, timeouts, missing results and fallback reading.
Updates and rollback (planned). Define version change control, revalidation triggers, stop-use criteria and a tested rollback route.
Local implementation checklist
Agree the evidence and acceptance owner with your team and suppliers. Checkmarks apply to this page only and are not acceptance receipts.
Sources & review detailsFDA identity, research record, source ledger, and history
Regulatory identity
FDA record and catalog context
The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.
This audit distinguishes completed source review from fields that have not yet been researched.
Human reviewedStatus
2026-09-06Last searched
20Fields reviewed
10Source classes checked
0Screened PubMed leads
0Screened trial leads
0Unreviewed FDA recall leads
Stored literature-index and trial-registry candidate arrays were empty and screened. This does not establish absence of literature; current vendor page links newer papers/posters that were not fully reviewed or promoted here. The current discovery snapshot contains 0 PubMed and 0 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.
Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.
Source classes: fda ai list, acr ai central product, fda decision summary, vendor product page, literature index, trial registry, stored candidate metadata, pubmed, clinical trials, openfda device recall
Field review details
Recorded state, verification date, notes and sources for fields without a publishable value. Conflicting records stay explicitly unsettled here; no plain settled value is shown for them.
Public pricing: Not verified - checked 2026-09-06 - Exact FDA submission
Reviewed product page offers contact/demo access, not a verified license, connector, edge-device or implementation price.
Pricing model: Not verified - checked 2026-09-06 - Exact FDA submission
Per-cycle, per-exam and site licensing terms remain unresolved.
Setup and integration fees: Not yet reviewed
Recurring fees: Not yet reviewed
Minimum commitment: Not yet reviewed
Contract duration: Not yet reviewed
Renewal terms: Not yet reviewed
Cancellation terms: Not yet reviewed
Support and service terms: Not yet reviewed
Trial or pilot terms: Not yet reviewed
Reimbursement: Not publicly available - checked 2026-10-26 - Exact FDA submission
Bounded web search on 2026-10-26 (query: "Mim Fertility reimbursement CPT"; top results reviewed) found no vendor or payer page stating coding, coverage or payment for this product. No result was a vendor or payer page naming this product with coding or payment; any results were general billing guidance. This records what was found, not that none exists.
Data hosting location: Not yet reviewed
Data retention: Not yet reviewed
Documented data use: Not yet reviewed
Hardware requirements: Not yet reviewed
Network requirements: Not yet reviewed
Identity and access: Not yet reviewed
Security: Not verified - checked 2026-09-06 - Exact FDA submission
Family FAQ makes hosting/encryption statements, but scoped dated security evidence and exact-US-configuration data-processing terms were not established.
Installation timeline: Not yet reviewed
Training: Not verified - checked 2026-09-06 - Exact FDA submission
Exact connector/operator training curriculum, competency assessment and costs require confirmation.
Monitoring: Not verified - checked 2026-09-06 - Exact FDA submission
Contracted post-installation quality monitoring and incident-handling responsibilities were not established.
Authorized purpose: Alturion Series diagnostic ultrasound systems acquire and display ultrasound images and fluid-flow information for the labeled fetal, abdominal, cardiac, cephalic, obstetric, musculoskeletal, ophthalmic, urologic, vascular, small-organ, and lung examinations.
Modality
Ultrasound
Anatomy
Fetus; abdomen; pelvis; small organs; head; heart; peripheral vessels; musculoskeletal anatomy; ophthalmic; urologic organs; and lung
Authorized purpose: Supervised automatic ultrasound image acquisition of hand and wrist joints in adults being investigated or monitored for musculoskeletal disease.
Authorized purpose: WatchMate Software v1.2.0 processes transesophageal echocardiography data to reconstruct the left atrial appendage and assist preprocedural planning and device sizing during left-atrial-appendage closure.
Copy this public context and add the field, proposed wording and original source before sending. Nothing here is submitted automatically. Form-specific prefill has not been verified.
Permission to display a submission is not evidence verification. A submission enters editorial review; it does not approve a public change. Form availability, data entry, receipt, review and publication are separate steps. Data entry and receipt remain unverified.
Accepted repository change history
No entry has been added to this scoped change history for this record. This is not proof that the record never changed.